Lack of pharmacokinetic drug–drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors

被引：0
|
作者：
Ding Wang
Fadi Braiteh
James J. Lee
Crystal S. Denlinger
Dale R. Shepard
Archana Chaudhary
Yong Lin
Ling Gao
Christopher Asakiewicz
Federico Nasroulah
Patricia LoRusso
机构：
[1] Henry Ford Hospital,
[2] Comprehensive Cancer Centers of Nevada,undefined
[3] University of Pittsburgh School of Medicine,undefined
[4] Fox Chase Cancer Center,undefined
[5] Cleveland Clinic,undefined
[6] Eli Lilly and Company,undefined
[7] Eli Lilly and Company,undefined
[8] Yale Cancer Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Pharmacokinetics; Drug–drug interactions; Ramucirumab; Irinotecan; SN-38; FOLFIRI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：727 / 733
页数：6
相关论文
共 50 条
  • [31] Lack of pharmacokinetic drug interaction between olmesartan medoxomil and amlodipine besylate during coadministration
    Salazar, D.
    Lee, J.
    Shenouda, M.
    Rohatagi, S.
    JOURNAL OF HYPERTENSION, 2007, 25 : S237 - S237
  • [32] Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, anti leucovorin in patients with advanced solid tumors
    Saltz, LB
    Kanowitz, J
    Kemeny, NE
    Schaaf, L
    Spriggs, D
    Staton, BA
    Berkery, R
    Steger, C
    Eng, M
    Dietz, A
    Locker, P
    Kelsen, DP
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) : 2959 - 2967
  • [33] Lack of Drug-Drug Interaction between Maribavir and Voriconazole
    Song, I. H.
    Ilic, K.
    Wu, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 779 - 779
  • [34] Lack of drug-drug interaction between cerivastatin and nifedipine
    Sachse, R
    Brendel, E
    Muck, W
    Rohde, G
    Ochmann, K
    Horstmann, R
    Kuhlmann, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (08) : 409 - 413
  • [35] Multiple drugsVarious toxicities, pharmacokinetic drug interaction and lack of efficacy
    Reactions Weekly, 2024, 2001 (1) : 261 - 261
  • [36] Lack of pharmacokinetic drug-drug interaction between ciclesonide and erythromycin. (vol 43, pg 264, 2005)
    Nave, R
    Drollmann, A
    Steinijans, VW
    Zech, K
    Bethke, TD
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (10) : 506 - 506
  • [37] Lack of a Clinically Significant Pharmacokinetic Drug-Drug Interaction between Sofosbuvir and GS-5816 in Healthy Volunteers
    Mogalian, Erik
    German, Polina
    Brainard, Diana M.
    Link, John O.
    McNally, John
    Han, Lingling
    Kearney, Brian P.
    HEPATOLOGY, 2013, 58 : 431A - 431A
  • [38] A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Yamada, Yasuhide
    Honda, Kazunori
    Asahina, Hajime
    Tamura, Yosuke
    Hozak, Rebecca R.
    Gao, Ling
    Suzukawa, Kazumi
    Enatsu, Sotaro
    Tamura, Tomohide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (04) : 298 - 305
  • [39] A phase 1, open-label, drug–drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors
    Mingxiang Liao
    Krzysztof G. Jeziorski
    Monika Tomaszewska-Kiecana
    István Láng
    Marek Jasiówka
    Viera Skarbová
    Piotr Centkowski
    Rodryg Ramlau
    Maria Górnaś
    John Lee
    Sarah Edwards
    Jenn Habeck
    Eileen Nash
    Nikolay Grechko
    Jim J. Xiao
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 887 - 897
  • [40] Pharmacokinetic drug interaction between propofol and remifentanil?
    Ludbrook, GL
    Upton, RN
    ANESTHESIA AND ANALGESIA, 2003, 97 (03): : 924 - 925
12345